Cargando…
Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression
Glioblastoma (GBM) is the most aggressive and lethal tumor of the central nervous system. The present study set out to identify reliable prognostic and predictive biomarkers for patients with GBM. RNA-sequencing data were obtained from The Cancer Genome Atlas database and DNA methylation data were d...
Autores principales: | Mao, Yu Kun, Liu, Zhi Bo, Cai, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377174/ https://www.ncbi.nlm.nih.gov/pubmed/32724403 http://dx.doi.org/10.3892/ol.2020.11729 |
Ejemplares similares
-
DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma
por: Tang, Yunliang, et al.
Publicado: (2020) -
Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer
por: Zhang, Ming, et al.
Publicado: (2020) -
Identification of prognostic biomarkers for glioblastomas using protein expression profiling
por: JUNG, YONG, et al.
Publicado: (2011) -
Construction of co‐expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma
por: Zhou, Jing, et al.
Publicado: (2021) -
Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis
por: Huang, Zhehao, et al.
Publicado: (2022)